A detailed history of Invesco Ltd. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Invesco Ltd. holds 155,269 shares of BHC stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
155,269
Previous 156,302 0.66%
Holding current value
$1.15 Million
Previous $1.09 Million 16.16%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$5.22 - $8.26 $5,392 - $8,532
-1,033 Reduced 0.66%
155,269 $1.27 Million
Q2 2024

Aug 13, 2024

SELL
$6.1 - $10.41 $18,806 - $32,094
-3,083 Reduced 1.93%
156,302 $1.09 Million
Q1 2024

May 14, 2024

SELL
$7.77 - $10.61 $9.31 Million - $12.7 Million
-1,197,871 Reduced 88.26%
159,385 $1.69 Million
Q4 2023

Feb 12, 2024

SELL
$6.53 - $8.23 $33,218 - $41,866
-5,087 Reduced 0.37%
1,357,256 $10.9 Million
Q3 2023

Nov 13, 2023

SELL
$7.69 - $9.71 $1.2 Million - $1.52 Million
-156,648 Reduced 10.31%
1,362,343 $11.2 Million
Q2 2023

Aug 11, 2023

BUY
$5.72 - $8.8 $757,390 - $1.17 Million
132,411 Added 9.55%
1,518,991 $12.2 Million
Q1 2023

May 12, 2023

BUY
$6.28 - $9.85 $1.06 Million - $1.67 Million
169,204 Added 13.9%
1,386,580 $11.2 Million
Q4 2022

Feb 13, 2023

SELL
$6.09 - $7.93 $6.1 Million - $7.95 Million
-1,002,395 Reduced 45.16%
1,217,376 $7.65 Million
Q3 2022

Nov 14, 2022

BUY
$4.58 - $9.21 $4.33 Million - $8.7 Million
944,835 Added 74.11%
2,219,771 $15.3 Million
Q2 2022

Aug 15, 2022

BUY
$7.06 - $23.63 $4.86 Million - $16.3 Million
688,477 Added 117.4%
1,274,936 $10.7 Million
Q1 2022

May 16, 2022

SELL
$21.6 - $27.79 $2 Million - $2.57 Million
-92,385 Reduced 13.61%
586,459 $13.4 Million
Q4 2021

Feb 14, 2022

SELL
$23.0 - $29.01 $1.26 Million - $1.6 Million
-54,989 Reduced 7.49%
678,844 $18.7 Million
Q3 2021

Nov 15, 2021

BUY
$25.04 - $30.06 $5.53 Million - $6.64 Million
221,043 Added 43.11%
733,833 $20.4 Million
Q2 2021

Aug 17, 2021

BUY
$27.43 - $32.7 $1.78 Million - $2.12 Million
64,798 Added 14.46%
512,790 $15 Million
Q1 2021

May 17, 2021

SELL
$21.37 - $34.38 $4 Million - $6.44 Million
-187,307 Reduced 29.48%
447,992 $14.2 Million
Q4 2020

Feb 16, 2021

SELL
$15.31 - $21.12 $828,791 - $1.14 Million
-54,134 Reduced 7.85%
635,299 $13.2 Million
Q3 2020

Nov 16, 2020

BUY
$14.88 - $20.13 $563,088 - $761,759
37,842 Added 5.81%
689,433 $10.7 Million
Q2 2020

Aug 14, 2020

BUY
$13.31 - $20.51 $1.38 Million - $2.13 Million
103,768 Added 18.94%
651,591 $11.9 Million
Q1 2020

May 15, 2020

SELL
$12.98 - $30.25 $2.62 Million - $6.11 Million
-202,032 Reduced 26.94%
547,823 $8.49 Million
Q4 2019

Feb 14, 2020

BUY
$18.89 - $31.89 $2.76 Million - $4.65 Million
145,872 Added 24.15%
749,855 $22.4 Million
Q3 2019

Nov 14, 2019

SELL
$20.88 - $25.66 $1.58 Million - $1.94 Million
-75,435 Reduced 11.1%
603,983 $13.2 Million
Q2 2019

Aug 14, 2019

SELL
$20.52 - $26.45 $628,548 - $810,189
-30,631 Reduced 4.31%
679,418 $17.1 Million
Q1 2019

May 15, 2019

SELL
$20.23 - $26.29 $1.72 Million - $2.24 Million
-85,074 Reduced 10.7%
710,049 $17.5 Million
Q4 2018

Feb 14, 2019

BUY
$17.64 - $28.32 $14 Million - $22.5 Million
795,123 New
795,123 $14.7 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.